Literature DB >> 6942428

Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody.

W Gerhard, A Taylor, Z Wroblewska, M Sandberg-Wollheim, H Koprowski.   

Abstract

We have produced hybridoma antibodies directed against immunoglobulins present in the cerebrospinal fluid of a patient with multiple sclerosis (MS). One hybridoma antibody recognized an idiotypic determinant of an immunoglobulin population [an idiotype (Id)] which constituted approximately 1% of the immunoglobulin present in the cerebrospinal fluid. The Id focused in the pH range 8.0-8.4. It was present at roughly 10- to 15-fold higher relative (compared to total immunoglobulin) concentration in cerebrospinal fluid than in serum of the homologous MS patient. The Id could not be detected in three cerebrospinal fluid samples and 28 serum samples of heterologous MS patients or in the serum of 43 optic neuritis patients. The Id persisted in the homologous MS patient at increased concentration over the entire (6 years) observation period. The Id could be shown to react with a Theiler murine encephalomyelitis virus strain WW which was isolated from mice after inoculation with periplaque white matter from brain in a histologically confirmed case of MS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6942428      PMCID: PMC319534          DOI: 10.1073/pnas.78.5.3225

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The analysis of the monoclonal immune response to influenza virus. I. Production of monoclonal anti-viral antibodies in vitro.

Authors:  W Gerhard; T J Braciale; N R Klinman
Journal:  Eur J Immunol       Date:  1975-10       Impact factor: 5.532

2.  IMMUNOLOGICAL CHARACTERIZATION OF VILYUISK HUMAN ENCEPHALOMYELITIS VIRUS.

Authors:  J CASALS
Journal:  Nature       Date:  1963-10-26       Impact factor: 49.962

3.  Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: correlation of the polypeptide profile with virulence.

Authors:  H L Lipton; A Friedmann
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

4.  Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies.

Authors:  Z Wroblewska; D H Gilden; M Wellish; L B Rorke; K G Warren; J S Wolinsky
Journal:  Lab Invest       Date:  1977-12       Impact factor: 5.662

Review 5.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

6.  Isoelectric focusing of CSF proteins in neurological diseases.

Authors:  K G Kjellin; O Vesterberg
Journal:  J Neurol Sci       Date:  1974-10       Impact factor: 3.181

7.  Immunoglobulin-containing cells in multiple-sclerosis plaques.

Authors:  M M Esiri
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

8.  Viral antibodies in multiple sclerosis.

Authors:  E Norrby
Journal:  Prog Med Virol       Date:  1978

9.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10

10.  Demyelinative myelopathy in mice induced by the DA virus.

Authors:  J R Lehrich; B G Arnason; F H Hochberg
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

View more
  3 in total

Review 1.  Immunoglobulin idiotypes; experimental and clinical applications.

Authors:  A K Abbas
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

2.  Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens.

Authors:  Zhiguo Liang; A S Manoj Kumar; Morris S Jones; Nick J Knowles; Howard L Lipton
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

Review 3.  Multiple sclerosis: basic concepts and hypothesis.

Authors:  M Rodriguez
Journal:  Mayo Clin Proc       Date:  1989-05       Impact factor: 7.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.